A

Allmed Solutions Ltd
TASE:ALMD

Watchlist Manager
Allmed Solutions Ltd
TASE:ALMD
Watchlist
Price: 33.2 ILS -2.35% Market Closed
Market Cap: 36m ILS
Have any thoughts about
Allmed Solutions Ltd?
Write Note

Allmed Solutions Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allmed Solutions Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
Allmed Solutions Ltd
TASE:ALMD
Cash from Investing Activities
-â‚Ş21.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
InspireMD Inc
NASDAQ:NSPR
Cash from Investing Activities
$4.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
60%
N
Nissan Medical Industries Ltd
TASE:NISA
Cash from Investing Activities
-â‚Ş9.6m
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
N/A
No Stocks Found

Allmed Solutions Ltd
Glance View

Market Cap
36m ILS
Industry
Health Care

Allmed Solutions Ltd. engages in the development, manufacture, and marketing of minimally invasive products internationally in various medical disciplines. Its products are used by physicians to treat a number of diseases and patients worldwide. The firm's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The firm's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.

ALMD Intrinsic Value
53.19 ILS
Undervaluation 38%
Intrinsic Value
Price
A

See Also

What is Allmed Solutions Ltd's Cash from Investing Activities?
Cash from Investing Activities
-21.6m ILS

Based on the financial report for Dec 31, 2023, Allmed Solutions Ltd's Cash from Investing Activities amounts to -21.6m ILS.

Back to Top